当前位置:首页 - 行情中心 - 赛诺医疗(688108) - 财务分析 - 现金流量表

赛诺医疗

(688108)

  

流通市值:73.64亿  总市值:73.64亿
流通股本:4.18亿   总股本:4.18亿

现金流量表

报告期2026-06-302026-03-312025-12-312025-09-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金342,960,089.73154,669,941.07575,128,400.61400,383,602.99
  收到的税费返还1,137,381.82274,215.71162,496.8983,860.41
  收到其他与经营活动有关的现金3,774,458.662,529,909.2523,623,843.7212,934,442.95
  经营活动现金流入小计347,871,930.21157,474,066.03598,914,741.22413,401,906.35
  购买商品、接受劳务支付的现金55,030,799.1126,290,569.5181,160,843.4951,658,466.73
  支付给职工以及为职工支付的现金110,959,111.0667,372,142.54197,769,912.37156,450,147.73
  支付的各项税费31,500,567.0913,899,120.653,311,310.5439,382,086.66
  支付其他与经营活动有关的现金56,226,582.7931,182,193.36104,798,326.7981,936,309.96
  经营活动现金流出小计253,717,060.05138,744,026.01437,040,393.19329,427,011.08
  经营活动产生的现金流量净额94,154,870.1618,730,040.02161,874,348.0383,974,895.27
二、投资活动产生的现金流量:
  收回投资收到的现金50,000,000---
  取得投资收益收到的现金80,555.56---
  处置固定资产、无形资产和其他长期资产收回的现金净额16,000-34,300.4134,352.25
  投资活动现金流入的平衡项目0-00
  投资活动现金流入小计50,096,555.56-34,300.4134,352.25
  购建固定资产、无形资产和其他长期资产支付的现金12,430,218.198,483,346.3545,800,047.7231,015,450.99
  投资支付的现金50,000,000---
  投资活动现金流出小计62,430,218.198,483,346.3545,800,047.7231,015,450.99
  投资活动产生的现金流量净额-12,333,662.63-8,483,346.35-45,765,747.31-30,981,098.74
三、筹资活动产生的现金流量:
  吸收投资收到的现金78,072,80078,072,80013,534,40011,534,400
  其中:子公司吸收少数股东投资收到的现金69,600,000-2,000,000-
  取得借款收到的现金123,440,000105,440,00067,400,00062,400,000
  收到其他与筹资活动有关的现金6,919,9003,486,55032,914,150-
  筹资活动现金流入小计208,432,700186,999,350113,848,55073,934,400
  偿还债务支付的现金93,200,00093,200,00076,500,00028,500,000
  分配股利、利润或偿付利息支付的现金1,475,114.18756,724.434,194,500.023,234,148.38
  支付其他与筹资活动有关的现金160,621,434.89123,478,014.1742,896,072.7828,536,424.2
  筹资活动现金流出小计255,296,549.07217,434,738.6123,590,572.860,270,572.58
  筹资活动产生的现金流量净额-46,863,849.07-30,435,388.6-9,742,022.813,663,827.42
四、汇率变动对现金及现金等价物的影响-1,040,589.32-236,435.78-1,635,126.9-634,051.61
五、现金及现金等价物净增加额33,916,769.14-20,425,130.71104,731,451.0266,023,572.34
  加:期初现金及现金等价物余额396,406,143.96396,406,143.96291,674,692.94291,674,692.94
  期末现金及现金等价物余额430,322,913.1375,981,013.25396,406,143.96357,698,265.28
补充资料:
  净利润55,576,065.16-47,465,942.71-
  资产减值准备5,997,143.8-3,912,065.46-
  固定资产和投资性房地产折旧11,231,231.82-24,620,748.51-
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧11,231,231.82-24,620,748.51-
  无形资产摊销19,015,373.17-40,239,087.62-
  长期待摊费用摊销1,505,822.87-18,366,136.15-
  处置固定资产、无形资产和其他长期资产的损失1,590.71---
  固定资产报废损失1,295.71-73,578.78-
  财务费用3,073,076.15-6,681,424.74-
  投资损失-75,995.81---
  递延所得税11,566,945.65-20,960,361.82-
  其中:递延所得税资产减少14,494,731.38-26,292,261.26-
    递延所得税负债增加-2,927,785.73--5,331,899.44-
  存货的减少-922,898.61-4,140,923.8-
  经营性应收项目的减少47,314.51--16,592,780.43-
  经营性应付项目的增加-18,059,114.33-213,120.87-
  其他--986,660-
  现金的期末余额430,322,913.1-396,406,143.96-
  减:现金的期初余额396,406,143.96-291,674,692.94-
  现金及现金等价物的净增加额33,916,769.14-104,731,451.02-
公告日期2026-08-272026-04-292026-03-262025-10-31
审计意见(境内)标准无保留意见
TOP↑